The Honourable Ginette Petitpas Taylor, Minister of Health announces new measures to reduce barriers to treatment and $231 M to address the opioid crisis

Monday, March 26, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

New measures aim to reduce barriers to methadone and diacetylmorphine for the treatment of opioid use disorder and emergency funding for treatment to tackle the opioid crisis

OTTAWA, March 26, 2018 /CNW/ -  The opioid crisis continues to have a devastating impact on families and communities across the country. In 2017 alone, projections suggest over 4,000 people will have lost their lives
as a result of this epidemic. Despite significant actions taken to date, more needs to be done to help address the crisis and save lives.

Today, the Honourable Ginette Petitpas Taylor, Minister of Health, announced a number of important initiatives to help address the opioid crisis.

First, the Minister announced that the Government of Canada is removing barriers to accessing diacetylmorphine (prescription heroin) and methadone for the treatment of opioid use disorder. These regulatory amendments will help Canadians have greater access to a comprehensive array of treatment options. For example, for methadone, health care practitioners will be able to prescribe and administer methadone treatment without needing to apply for an exemption from federal law. For diacetylmorphine, the amendments will provide flexibility by allowing patients to receive the product outside a hospital setting, such as substance use disorder clinics, thereby allowing patients to balance their daily responsibilities with their treatment. The regulatory amendments were published in the Canada Gazette, Part II on March 21, 2018.

Second, Minister Petitpas Taylor announced $18 million in federal investments for six innovative projects under the Substance Use and Addictions Program, and ten research projects related to opioids funded through the Canadian Institutes of Health Research (CIHR). These projects will explore drug checking in supervised consumption sites, opioid use in pain management, the development of guidance material for prevention and treatment of opioid use disorder, and to look at how opioid-related treatment can better address the needs of women.

Third, the Health Minister announced details of the $231.4 million investments proposed in Budget 2018 to improve access to treatment, address stigma and gather more data to help address the opioid crisis. These investments include: 

  • $150 million in emergency funding for provinces and territories to increase access to evidence-based treatment;
  • $13.5 million towards innovative approaches to treatment and prevention through Health Canada's Substance Use and Addictions Program;
  • $18.7 million over five years to address stigma faced by people who use drugs, including launching a new national, multi-year public education campaign to help reshape Canadians' attitudes and perceptions about people who use drugs;
  • $31.6 million to equip border officers with tools to intercept fentanyl and other dangerous substances at the border; and
  • $17.9 million to expand the evidence base to inform and evaluate our response to the opioid crisis, including accelerating access to public health data and analysis.

Minister Petitpas Taylor concluded the event by thanking the Canadian Research Initiative in Substance Misuse (CRISM) for its recently released report and recommendations on removing regulatory barriers to methadone treatment and its expertise on developing a national clinical practice guideline on the management of opioid use disorders. These recommendations helped shape the regulatory amendments announced today on methadone.

Quotes

"We should not judge people with substance use problems but instead make sure they are getting the help they need, when they want it. The changes we announce today will allow health care practitioners to prescribe and administer methadone treatment without needing to apply for an exemption. The new funding proposed in Budget 2018 will also help us improve treatment, reduce stigma and gather more data to reverse the heartbreaking trend of opioid-related deaths in Canada."

The Honourable Ginette Petitpas TaylorMinister of Health

"There's no doubt that the illegal production and trafficking of opioids, including fentanyl, have contributed to a public health crisis in Canada. We recognize that this is a complex social, health and public safety issue and we are committed to an approach to this crisis that is comprehensive, collaborative, compassionate and evidence-based."

The Honourable Ralph GoodaleMinister of Public Safety and Emergency Preparedness

"It is important for us to signal to those who use drugs and the people around them that treatment is an individualized journey. Better access to treatment options and additional funding announced today will enhance our collective ability to respond to address the opioid crisis in a comprehensive and collaborative manner."

Dr. Theresa TamChief Public Health Officer of Canada

Quick Facts

  • Methadone and diacetylmorphine, or pharmaceutical-grade heroin, are medications that can be used to treat opioid use disorder.
  • Health Canada has heard from stakeholders that any barriers to accessing treatment can deter patients and doctors from using them. This is why Health Canada is removing federal barriers to methadone and diacetylmorphine.
  • The Government of Canada is focusing on three key areas as part of its comprehensive and evidence-based approach to saving lives and addressing the opioid crisis:
    • Working with provinces and territories to increase access  to treatment;
    • Supporting innovative approaches to addressing the opioid crisis; and
    • Addressing the stigma related to opioid use.
  • The Substance Use and Addictions Program is a federal contributions program that provides financial support to provinces, territories, non-governmental organizations and key stakeholders to strengthen responses to drug and substance use issues in Canada.
  • Through the Canadian Institutes of Health Research, the Government is funding scientists whose work is helping to provide the evidence of which interventions work best to treat pain, prevent opioid overdoses and how to treat opioid use disorder and promote harm reduction.

Associated Links

  • Budget 2017 Brings Additional Federal Funding to Fight the Opioid Crisis
  • Government of Canada Actions on Opioids: 2016 and 2017
  • National report: Apparent opioid-related deaths in Canada
  • National consultation on the Section 56 exemption requirement for methadone prescribing
  • Management of opioid use disorders: a national clinical practice guideline

 

SOURCE Health Canada

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store